Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).


CSE:THC - Post by User

Post by check21on Jun 09, 2021 3:18pm
74 Views
Post# 33356552

The Preventing Obesity

The Preventing ObesitySponsored post:
Did you know that about 18.5% of children, some as young as two years old, are considered obese? But I have discovered in a some unconventional ways of preventing obesity. Wanna know more? Take a look here

These other sectors' preclinical trial is said to be designed to gather information about our psilocybin based drug treatment to potentially help with weight loss and treat obesity and related illnesses. They appear to be working with the University of British Columbia to carry out their preclinical research.
 
They appear to be rooting to have enough information from their preclinical trial to apply for their planned Phase 2 Human Clinical Trial in the Spring of 2021. Check disclaimer on profile and landing page.
<< Previous
Bullboard Posts
Next >>